...
首页> 外文期刊>Pharmaceutical Nanotechnology >Solid lipid Particles as Drug Carriers – Effects of Particle Preparation Methods and Lipid Excipients on Particle Characteristics
【24h】

Solid lipid Particles as Drug Carriers – Effects of Particle Preparation Methods and Lipid Excipients on Particle Characteristics

机译:固体脂质颗粒作为药物载体 - 颗粒制备方法和脂质赋形剂对颗粒特征的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Oral delivery of biopharmaceuticals is limited by the absorption barriers inthe Gastrointestinal Tract (GIT) such as low permeability across the biological membranes and the enzymaticdegradation by proteases. In this study, lipid-based drug delivery systems were proposed toovercome these obstacles.Objective: The aim of this study was to evaluate the effect of particle preparation methods and excipientson the characteristics of Solid Lipid Microparticles (SLM) and Solid Lipid Nanoparticles (SLN).Method: Different triglycerides (TG) were used as the major excipients for the SLM and SLN. Insulinwas used as the model protein; insulin-phospholipid (PL) was prepared to increase drug lipophilicityand compatibility with lipid excipients. Four methods were used for preparing lipid particles, i.e. a HotMelting Dispersion (HMD) technique, a Solvent Evaporation (SE) method, a modified Solvent Evaporation(mSE) method and a Spray Drying technique. The lipid particles were evaluated in terms ofsize, size distribution, surface morphology and drug Entrapment Efficiency (EE).Results: The results suggested that SE method was the most suitable method for preparing insulin-PLloaded Solid Lipid Particles (SLP). No differences were observed when the SLP with a Long ChainTriglyceride (LCT) either a Medium Chain Triglyceride (MCT) in term of size. 70-90% of the lipidifiedinsulin was incorporated in the lipid particles.Conclusion: The preparation methods affected the size and morphology of SLP significantly, and theselection of lipid excipient should be done based on specific application requirements. Furthermore,the use of the lipidified protein was an efficient way to encapsulate protein in lipid carriers.
机译:背景:生物药物的口腔递送是受胃肠道(Git)的吸收屏障(Git)的限制,例如通过生物膜的低渗透性和蛋白酶的酶促致抗体。在这项研究中,提出了脂质的药物递送系统,提出了这些障碍。目的:本研究的目的是评估颗粒制备方法和Excipectors的效果,固体脂质微粒(SLM)和固体脂质纳米粒子(SLN)的特性。方法:使用不同的甘油三酯(TG)作为SLM和SLN的主要赋形剂。胰岛素用作模型蛋白质;制备胰岛素 - 磷脂(PL)以增加与脂质赋形剂的药物亲脂性和相容性。用于制备脂质颗粒的四种方法,即Hotmelting分散体(HMD)技术,溶剂蒸发(Se)方法,改性溶剂蒸发(MSE)方法和喷雾干燥技术。在大小,尺寸分布,表面形态和药物夹带效率(EE)中评估脂质颗粒。结果表明SE方法是制备胰岛素 - 载体固体脂质颗粒(SLP)的最合适的方法。当具有长的甘油酯(LCT)的SLP以尺寸期间的中链甘油三酯(MCT)而没有观察到差异。将70-90%的脂质浸润素含入脂质颗粒中。结论:制备方法显着影响SLP的大小和形态,并且脂质赋形剂的测量应根据具体的应用要求进行。此外,使用脂质化蛋白质是在脂质载体中包封蛋白质的有效方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号